ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.62
0.96%
US Tech 100
18,064.80
0.02%
S&P 500
5,277.51
0.80%
US Dollar vs CAD
1.36525
-0.01%
Bitcoin
67,631.59
0.22%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Immunome Inc (IMNM)

  7. Immunome Inc (IMNM) News

IMNM Immunome Inc

14.99
0.28 (1.90%)
May 31 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Immunome Inc IMNM NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.28 1.90% 14.99 19:00:00
Open Price Low Price High Price Close Price Previous Close
15.32 14.61 15.81 14.94 14.71
more quote information »

Recent News

Date Time Source Heading
5/20/202407:00BWImmunome Announces Completion of Purchase of Assets from..
5/17/202416:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/17/202407:00BWImmunome Announces Promotion of Max Rosett to Chief..
5/14/202407:48EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
5/14/202407:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/14/202407:02EDGAR2Form 8-K - Current report
5/14/202407:00BWImmunome Reports First Quarter 2024 Financial Results and..
5/08/202407:00BWImmunome to Present at 2024 Bank of America Healthcare..
5/02/202407:00BWImmunome Appoints Kinney Horn as Chief Business Officer
4/25/202407:26BWImmunome Appoints Sandra M. Swain to Board of Directors
4/05/202407:00BWImmunome to Present Preclinical Data for IM-3050, Its Lead..
3/28/202415:02BWImmunome Reports Full Year 2023 Financial Results and..
3/26/202407:00BWImmunome Completes Acquisition of AL102, a Phase 3 Asset for..
3/07/202407:00BWImmunome to Participate in the Leerink Partners Global..
3/01/202407:00BWImmunome to Participate in the TD Cowen 44th Annual..
2/21/202420:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202420:07EDGAR2Form 3 - Initial statement of beneficial ownership of..
2/20/202407:15BWImmunome Recognizes Ayala Pharmaceuticals’ Announced..
2/16/202415:05BWImmunome Announces Closing of Public Offering and Full..
2/14/202415:11EDGAR2Form 8-K - Current report
2/14/202415:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/13/202421:38BWImmunome Announces Pricing of Public Offering of Common..
2/13/202415:36EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/13/202415:10EDGAR2Form 8-K - Current report
2/13/202415:05BWImmunome Announces Proposed Public Offering of Common Stock
2/12/202413:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/06/202407:05EDGAR2Form 8-K - Current report
2/05/202407:00BWImmunome to Present at the Guggenheim Healthcare Talks 6th..
2/02/202415:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
1/31/202419:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/31/202419:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/11/202416:27EDGAR2Form 8-K - Current report
1/08/202406:05EDGAR2Form 8-K - Current report
1/08/202406:00BWImmunome Exclusively Licenses Zentalis ROR1 Antibody-Drug..
1/04/202416:40EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/04/202407:00BWImmunome Appoints Phil Roberts as Chief Technical Officer
1/03/202407:00BWImmunome to Present at the 42nd Annual J.P. Morgan..
1/02/202407:05EDGAR2Form 8-K - Current report
1/02/202407:00BWImmunome Appoints Carol A. Schafer to Board of Directors
12/29/202316:00EDGAR2Form 8-K - Current report
12/26/202307:35EDGAR2Form 8-K - Current report
12/26/202307:30GLOBEAtreca Announces Asset Purchase Agreement for Sale of..
12/15/202318:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/05/202320:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/27/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
11/22/202315:02EDGAR2Form 8-K/A - Current report: [Amend]
11/16/202315:08EDGAR2Form S-3 - Registration statement under Securities Act of..
11/15/202305:03EDGAR2Form 8-K - Current report
11/10/202307:00BWImmunome to Present at the Stifel 2023 Healthcare Conference
11/09/202315:52EDGAR2Form 8-K - Current report

Your Recent History

NASDAQ
IMNM
Immunome
COIN
MARCOUSD
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved